Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial

  • Joshua M. Hare
  • , Darcy L. DiFede
  • , Angela C. Rieger
  • , Victoria Florea
  • , Ana M. Landin
  • , Jill El-Khorazaty
  • , Aisha Khan
  • , Muzammil Mushtaq
  • , Maureen H. Lowery
  • , John J. Byrnes
  • , Robert C. Hendel
  • , Mauricio G. Cohen
  • , Carlos E. Alfonso
  • , Krystalenia Valasaki
  • , Marietsy V. Pujol
  • , Samuel Golpanian
  • , Eduard Ghersin
  • , Joel E. Fishman
  • , Pradip Pattany
  • , Samirah A. Gomes
  • Cindy Delgado, Roberto Miki, Fouad Abuzeid, Mayra Vidro-Casiano, Courtney Premer, Audrey Medina, Valeria Porras, Konstantinos E. Hatzistergos, Erica Anderson, Adam Mendizabal, Raul Mitrani, Alan W. Heldman

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)526-537
Number of pages12
JournalJournal of the American College of Cardiology
Volume69
Issue number5
DOIs
StatePublished - Feb 7 2017
Externally publishedYes

ASJC Scopus Subject Areas

  • Cardiology and Cardiovascular Medicine

Keywords

  • endothelial function
  • heart failure
  • idiopathic dilated cardiomyopathy
  • immune biomarker
  • stem cell therapy

Cite this